banner

RECENT RESEARCH PROJECTS

Prof Galassi was coinvestigators of the following research projects at the Division of Cardiology, Department of Internal Medicine and Systemic Disease of the University of Catania.


2003-2007. Principal Investigator in the FINESSE trial (Facilitated Intervention with Enhanced reperfusion Speed to Stop Events).
This is a multicenter randomized double blind placebo controlled trial for patients presenting with ST segment elevation myocardial infarction. The objective of the trial is to demonstrate that rapid administration of aspirin abciximab, reteplase, and heparin followed by early catheterization and intervention, when not controindicated, is superior to the administration of aspirin and heparin followed by diagnostic angiography and primary intervention with abciximab after angiography when not controindicated.


2008-2011 Principal Investigator of the IRCTO (Italian Registry on Chronic Total Occlusion).
This is a observational Registry executed among 61 italians centers whose objective was that of assessing prospectively the prevalence, therapeutic choices, and short and mid-term prognosis (up to 3 years) of patients with angiographic evidence of a chronic total occlusion in a major coronary artery.


2008-2011 Study Coordinator of the ERCTO (European Registry on Chronic Total Occlusion).
This is a observational web based registry executed among 32 european operators whose objective was that of assessing retrospectively patients with angiographic evidence of a chronic total occlusion in a major coronary artery, who underwent revascularization by coronary angioplasty: percentage of revascularization success, techniques of choice, and short and mid-term prognosis (up to 3 years) are going to be evaluated in this registry.
 
2011-2014 Principal Investigator in the Board of Steering Committee of the EURO CTO Trial
(A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for the Treatment of Chronic Total Coronary Occlusions). This is a randomized study, executed by expert CTO operators around Europe, who assess the efficacy and safety of percutaneous revascularization for chronic total coronary occlusions (CTO) in comparison to medical therapy in patients with coronary artery disease and stable angina pectoris.
 
The web-based registry ERCTO (www.ercto.org)

For browsing ERCT registry please go to: www.ercto.org